PGIM India Healthcare Fund

ThematicDirect and Regular plans, Growth and IDCW options

Data as on 30-10-2026

PGIM India Healthcare Fund is a Thematic fund run by PGIM India Mutual Fund. On 30-09-2026, it managed ₹130 Cr of investors' money. In the year to 30-10-2026, its Direct plan returned 18.1% and its Regular plan returned 16.1%. Its benchmark, BSE Healthcare TRI, returned 12.4% over the same year.

NAV (Direct plan): ₹12.10; ▲ 1.00%30-10-2026
NAV (Regular plan): ₹11.71; ▲ 0.95%30-10-2026
Expense ratio: 0.98%Direct2.65%Regular; 0.98%; A year
Riskometer: Very High; Set by the fund house
1 year return: 18.1%Direct16.1%Regular; 18.1%; Total

PGIM India Healthcare Fund NAV Today

NAV on 30-10-2026: Direct Plan Growth ₹12.10 (up 1.00% that day); Regular Plan Growth ₹11.71 (up 0.95% that day).

This fund (Direct plan)

₹12.10

PGIM India Healthcare Fund Returns vs BSE Healthcare TRI

Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.

Trailing returns
Period	1M	3M	6M	1Y	3Y	5Y	10Y
This fund (Direct)	−1.22%	−1.14%	+15.90%	+18.05%	--	--	--
This fund (Regular)	−1.35%	−1.60%	+14.92%	+16.06%	--	--	--
BSE Healthcare TRI	+0.24%	−0.99%	+12.80%	+12.37%	+23.01%	+15.61%	+12.48%
Thematic average	−2.09%	−4.52%	+0.86%	−1.22%	--	--	--
Best in Thematic	+11.54%	+11.27%	+22.16%	+75.71%	--	--	--
Worst in Thematic	−16.05%	−11.74%	−13.97%	−22.44%	--	--	--
Rank in Thematic	71/235	43/232	7/232	8/215	--	--	--

Category rows compare the Direct plans of 235 Thematic funds. Rank 1 is the highest return.

PGIM India Healthcare Fund Year-wise Returns

Return of each calendar year
Year	Direct	Regular	BSE Healthcare TRI
2026to date	+20.76%	+19.00%	+15.08%
2025	−0.99%	−2.67%	−2.72%

PGIM India Healthcare Fund Rolling Returns

The return of every holding period in the fund's history, not only the one that ends today

Rolling returns

Each point is the yearly return of one 1-year holding period, plotted on the day it ended. There are 217 periods, one for each trading day from 11-12-2025 to 30-10-2026.

−10%0%10%20%30%

Jan 2025
to
Jan 2026Mar 2025
to
Mar 2026Apr 2025
to
Apr 2026Jun 2025
to
Jun 2026Aug 2025
to
Aug 2026Oct 2025
to
Oct 2026

PGIM India Healthcare Fund (Direct)BSE Healthcare TRI

Every holding period at a glance

Period	Periods	Median	Lowest	Highest	With a loss	Benchmark median	Beat benchmark
1 year	217	13.8%	−3.0%	29.3%	9%	10.2%	97%

Lumpsum: the yearly rate (CAGR) from the NAV on a period's first day to the NAV on its last. SIP: the XIRR of the monthly instalments and their value on the last day. "With a loss" counts the periods that ended below the money put in. "Beat benchmark" counts the periods in which the fund did better than BSE Healthcare TRI over the same days. Past returns do not promise future returns.

PGIM India Healthcare Fund Risk

How much it swings, and the falls an investor had to sit through

Risk and return

Measure	PGIM India Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+18.05%	+12.37%
Standard deviation	12.68%	13.56%
Sharpe ratio	1.01	0.53
Sortino ratio	1.50	0.77
Maximum drawdown	−10.0% (23-10-2026)	−9.9% (23-10-2026)
Beta	0.87	1.00
Alpha	+6.61%	0.00%

From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Measure	PGIM India Healthcare Fund (Direct)This fund	BSE Healthcare TRI
Return (CAGR)	+10.77%	+7.24%
Standard deviation	13.07%	14.68%
Sharpe ratio	0.40	0.11
Sortino ratio	0.54	0.15
Maximum drawdown	−14.4% (28-02-2025)	−16.2% (28-02-2025)
Beta	0.84	1.00
Alpha	+3.79%	0.00%

From daily NAVs, 11-12-2024 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta: 1 moves with the benchmark, below 1 moves less. Alpha: return beyond what its beta explains, a year.

Drawdowns

How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.

−20%−15%−10%−5%0%

20252026

PGIM India Healthcare Fund (Direct)BSE Healthcare TRI

	Worst fall	High before it	Bottom	Back at the high	Time to climb back	Below its high today
PGIM India Healthcare Fund (Direct)	−14.4%	07-01-2025	28-02-2025	15-07-2025	5 months	−5.1%
BSE Healthcare TRI	−16.2%	02-01-2025	28-02-2025	29-07-2025	5 months	−3.8%

From the Direct plan's daily NAV since 11-12-2024, adjusted for unit splits, and BSE Healthcare TRI over the same days. "Time to climb back" runs from the bottom to the first day back at the old high.

PGIM India Healthcare Fund vs Other Thematic Funds

The five Thematic funds with the best three year return, and this fund. Direct plans.

Fund name	Rank	AUM (Cr)	Exp. ratio	1Y return	3Y return	3Y alpha	3Y beta	3Y Sharpe	3Y Sortino
Nippon India Taiwan Equity Fund	1/133	1,147	1.08%	+75.71%	+54.78%	--	--	1.38	2.03	Compare
HDFC Defence Fund	2/133	11,493	0.90%	+13.79%	+34.76%	−0.18%	0.83	1.12	1.54	Compare
HDFC Pharma and Healthcare Fund	3/133	3,501	1.05%	+23.12%	+30.53%	+8.23%	0.96	1.74	2.49	Compare
SBI Healthcare Opportunities Fund	4/133	5,870	1.01%	+17.12%	+24.60%	+3.61%	0.88	1.42	2.03	Compare
Aditya Birla Sun Life International Equity Fund	5/133	352	2.00%	+13.97%	+24.46%	--	--	1.49	2.16	Compare
PGIM India Healthcare Fund	8/215	130	0.98%	+18.05%	--	--	--	--	--

AUM is each fund's size at the end of its last reported month, from its own portfolio file. We calculate the risk ratios from daily NAVs over the last three years. The risk-free return is what NSE's overnight rate index earned over the same years. Alpha and beta compare each fund with its own benchmark's TRI. "--" means we have no figure: for alpha and beta, no daily series for that benchmark.

PGIM India Healthcare Fund Expense Ratio and Costs

What each plan charges a year, in force from 20-10-2026

Plan	Base expense ratio	Brokerage	Transaction costs	Levies and GST	Total expense ratio	Thematic median	Cost rank (1 = cheapest)
Direct	0.68%	0.06%	0.00%	0.24%	0.98%	1.18%	54/235
Regular	2.10%	0.06%	0.00%	0.49%	2.65%	2.41%	172/235

The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, the cost of executing trades, and statutory levies with GST. From AMFI's expense ratio file. Cost rank: where this plan comes when the Thematic funds' plans of the same type are sorted from the lowest total expense ratio to the highest.

Direct vs Regular: what the gap cost

Both plans own the same portfolio, so the difference in what they earned is the Regular plan's extra cost, taken out of its NAV.

Over the last	Regular	Direct	Direct earned more by	₹1 lakh became (Regular)	₹1 lakh became (Direct)
1 year	16.06%	18.05%	1.99%	₹1,16,060	₹1,18,050

Returns over more than 1 year are a rate a year (CAGR). ₹1 lakh invested once at the start of each period, valued on the last NAV.

PGIM India Healthcare Fund SIP Calculator

What a one-time or monthly investment in this fund would be worth today, from its own NAV history

Growth of an investment

Every month₹

Step up each year

PeriodFor

₹10,000 on the first trading day of every month, from 11-12-2024 to 30-10-2026: 23 instalments, ₹2,30,000 in all.

Investment	Invested	Value now	Gain	Return a year
Direct planPGIM India Healthcare Fund (Direct)	₹2,30,000	₹2,72,424	₹42,424	18.1%
Regular planPGIM India Healthcare Fund (Regular)	₹2,30,000	₹2,67,557	₹37,557	16.1%
BSE Healthcare TRI	₹2,30,000	₹2,61,855	₹31,855	13.7%
Category averageCategory average, 235 Thematic funds	₹2,30,000	₹2,36,889	₹6,889	3.0%

₹0₹1.0 L₹2.0 L₹3.0 L

20252026

Direct planPGIM India Healthcare Fund (Direct)Regular planPGIM India Healthcare Fund (Regular)BSE Healthcare TRICategory averageCategory average, 235 Thematic fundsAmount invested

From each plan's published NAV (Growth option), the benchmark's TRI and the category average, over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.

PGIM India Healthcare Fund Asset Allocation

Asset allocation as on 30-09-2026

What the fund holds

94.9%Equity

Asset	Fund	Category
Equity	94.9%	94.5%
Cash and others	5.1%	4.0%

Market cap of stocks

Market cap	Fund	Category
Large Cap	31.1%	45.7%
Mid Cap	31.6%	19.6%
Small Cap	25.1%	24.1%
Not on AMFI's list	7.0%	2.3%

Share of the whole fund. Category: the average of the Thematic funds that hold stocks. Groups follow AMFI's latest list, as SEBI defines them: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.

PGIM India Healthcare Fund Sector Allocation

Sector allocation of the fund's stocks as on 30-09-2026

Largest sectors

Pharmaceuticals & Biotechnology62.8%
Healthcare Services24.6%
Chemicals & Petrochemicals3.2%
Insurance2.1%
Retailing1.0%
Healthcare Equipment & Supplies0.8%
IT - Services0.4%

Sector changes

Sector	July 2026	August 2026	September 2026	Change
Pharmaceuticals & Biotechnology	63.1%	63.3%	62.8%	−0.3%
Healthcare Services	27.5%	25.7%	24.6%	−2.9%
Chemicals & Petrochemicals	2.8%	3.0%	3.2%	+0.4%
Insurance	0.9%	1.4%	2.1%	+1.2%
Retailing	0.7%	0.7%	1.0%	+0.3%

Each sector's share of the fund at the end of each month. The five largest sectors of September 2026. Change: from July 2026 to September 2026, in % of the fund.

PGIM India Healthcare Fund Portfolio Holdings

As on 30-09-2026 · 31 holdings · from the fund house's monthly portfolio

Holdings	Sector	Weight%	1M change
Divi's Laboratories Ltd.	Pharmaceuticals & Biotechnology	10.36%	+1.3%
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals & Biotechnology	10.25%	+8.6%
Torrent Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	8.49%	+5.3%
Ajanta Pharma Ltd.	Pharmaceuticals & Biotechnology	4.96%	+6.5%
Max Healthcare Institute Ltd.	Healthcare Services	4.71%	+10.9%
Dr. Lal Path Labs Ltd.	Healthcare Services	4.33%	+11.7%
Mankind Pharma Ltd.	Pharmaceuticals & Biotechnology	4.04%	0.0%
Manipal Health Enterprises Ltd.	Healthcare Services	3.68%	0.0%
Navin Fluorine International Ltd.	Chemicals & Petrochemicals	3.24%	+16.6%
Abbott India Ltd.	Pharmaceuticals & Biotechnology	3.12%	+9.5%
Krishna Inst of Medical Sciences Ltd.	Healthcare Services	2.99%	0.0%
Rubicon Research Ltd.	Pharmaceuticals & Biotechnology	2.99%	−12.8%
Neuland Laboratories Ltd.	Pharmaceuticals & Biotechnology	2.91%	0.0%
Aster DM Quality Care Ltd.	Healthcare Services	2.56%	0.0%
Sai Life Sciences Ltd	Pharmaceuticals & Biotechnology	2.54%	0.0%
ICICI Lombard General Insurance Co. Ltd.	Insurance	2.10%	+54.3%
Zydus Lifesciences Ltd.	Pharmaceuticals & Biotechnology	2.04%	+40.8%
Cipla Ltd.	Pharmaceuticals & Biotechnology	2.04%	0.0%
Lupin Ltd.	Pharmaceuticals & Biotechnology	1.93%	+52.7%
IPCA Laboratories Ltd.	Pharmaceuticals & Biotechnology	1.92%	+304.7%
Dr Agarwal's Eye Hospital Ltd.	Healthcare Services	1.86%	+66.2%
Anthem Biosciences Ltd.	Pharmaceuticals & Biotechnology	1.81%	0.0%
Global Health Ltd.	Healthcare Services	1.52%	0.0%
Gland Pharma Ltd.	Pharmaceuticals & Biotechnology	1.50%	+111.8%
Jupiter Life Line Hospitals Ltd.	Healthcare Services	1.46%	0.0%
Fortis Healthcare Ltd.	Healthcare Services	1.46%	+62.5%
Symbiotec Pharmalab Ltd.	Pharmaceuticals & Biotechnology	1.10%	New
Lenskart Solutions Ltd.	Retailing	0.99%	+38.9%
Molbio Diagnostics Ltd.	Healthcare Equipment & Supplies	0.80%	New
Orchid Pharma Ltd.	Pharmaceuticals & Biotechnology	0.79%	0.0%
Sagility Ltd.	IT - Services	0.40%	0.0%

PGIM India Healthcare Fund Stocks Bought and Sold

All changes are between August 2026 and September 2026

Stocks bought and sold in September 2026

Divi's Laboratories Ltd.	Added	+1.3%	10.36%
Sun Pharmaceutical Industries Ltd.	Added	+8.6%	10.25%
Torrent Pharmaceuticals Ltd.	Added	+5.3%	8.49%
Max Healthcare Institute Ltd.	Added	+10.9%	4.71%
Ajanta Pharma Ltd.	Added	+6.5%	4.96%
Dr. Lal Path Labs Ltd.	Added	+11.7%	4.33%
Rubicon Research Ltd.	Reduced	−12.8%	2.99%
Navin Fluorine International Ltd.	Added	+16.6%	3.24%
Abbott India Ltd.	Added	+9.5%	3.12%
Pfizer Ltd.	Sold out	−100%	was 2.12%
ICICI Lombard General Insurance Co. Ltd.	Added	+54.3%	2.10%
Zydus Lifesciences Ltd.	Added	+40.8%	2.04%
Lupin Ltd.	Added	+52.7%	1.93%
IPCA Laboratories Ltd.	Added	+304.7%	1.92%
Dr Agarwal's Eye Hospital Ltd.	Added	+66.2%	1.86%
Gland Pharma Ltd.	Added	+111.8%	1.50%
Fortis Healthcare Ltd.	Added	+62.5%	1.46%
Symbiotec Pharmalab Ltd.	New	New	1.10%
Lenskart Solutions Ltd.	Added	+38.9%	0.99%
Dr Agarwal's Health Care Ltd.	Sold out	−100%	was 0.86%
Molbio Diagnostics Ltd.	New	New	0.80%

A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.

What PGIM India Healthcare Fund bought and sold

PGIM India Healthcare Fund Portfolio Overlap

Funds with the most similar portfolios, across every fund house and category

Fund	Overlap	Holdings in common
Mirae Asset Healthcare FundThematic · Mirae Asset	54.0%	17	Compare
ITI Pharma and Healthcare FundThematic · ITI	53.2%	17	Compare
Mirae Asset Nifty 500 Healthcare ETFETF · Mirae Asset	53.0%	21	Compare
HDFC Pharma and Healthcare FundThematic · HDFC	52.5%	19	Compare
WhiteOak Capital Pharma and Healthcare FundSectoral · WhiteOak Capital	51.4%	22	Compare
Kotak Healthcare FundThematic · Kotak Mahindra	51.3%	18	Compare
Aditya Birla Sun Life Pharma and Healthcare FundThematic · Aditya Birla Sun Life	49.6%	17	Compare
Baroda BNP Paribas Health and Wellness FundThematic · Baroda BNP Paribas	49.3%	16	Compare

Overlap: for each holding both funds own, the smaller of its two weights, added up. 40% means 40% of each fund's money sits in positions the other also holds. From each fund's latest monthly portfolio, matched by ISIN. Cash and hedged positions are left out. Funds that overlap under 10% are not listed. A high overlap does not make two funds the same: their costs, lock-in and category can differ.

PGIM India Healthcare Fund Overview

Fund facts from the scheme summary document, as on 16-10-2026

Expense ratio (Direct): 0.98%
Expense ratio (Regular): 2.65%
Category: Thematic
Risk: Very High
Benchmark: BSE Healthcare TRI
Launch date: 06-12-2024
Minimum investment: ₹5,000
Minimum additional investment: ₹1,000
AUM: ₹130.33 Cr (30-09-2026)
Lock in: None
Scheme code (Direct): 153039
ISIN (Direct): INF663L01Z45
Scheme code (Regular): 153040
ISIN (Regular): INF663L01Z52
NAV history: From 11-12-2024, 1.9 years

Exit load: Exit load of 0.50%, if redeemed within 90 days.

Tax on PGIM India Healthcare Fund returns

PGIM India Healthcare Fund is taxed as an equity fund: 65% or more of it is in Indian stocks.
Units sold within 1 year: the gain is taxed at 20%.
Units held longer: gains above ₹1.25 lakh in a financial year, across all your equity funds and shares, are taxed at 12.5%.
IDCW (dividend) payouts are added to your income and taxed at your slab rate.
A stamp duty of 0.005% is deducted when you invest.

Rules in force from 23-07-2024 (Finance Act 2024). Tax depends on your own income; this is general information, not tax advice.

All plans and options

Plan	Option	NAV	As on
direct	Growth	₹12.10	30-10-2026
direct	IDCW	₹12.10	30-10-2026
regular	Growth	₹11.71	30-10-2026
regular	IDCW	₹11.71	30-10-2026

About PGIM India Healthcare Fund

PGIM India Healthcare Fund is a mutual fund from PGIM India Mutual Fund. Its category is Thematic. It was launched on 06-12-2024. Its benchmark is BSE Healthcare TRI. At the end of September 2026 it held 31 securities.

Fund Manager

Anandha Padmanabhan Anjeneyan
Fund manager of PGIM India Healthcare Fund, since 06-12-2024
Utsav Mehta
Fund manager of PGIM India Healthcare Fund, since 06-12-2024
Vivek Sharma
Fund manager of PGIM India Healthcare Fund, since 06-12-2024
and Mr. Puneet Pal
Fund manager of PGIM India Healthcare Fund, since 06-12-2024

See all funds of PGIM India Mutual Fund

AUM change

September 2026: ₹130.33 Cr; +4.14% from August 2026
August 2026: ₹125.15 Cr; +12.10% from July 2026
July 2026: ₹111.64 Cr; +8.14% from June 2026

AUM moves with money invested or taken out, and with the value of what the fund holds.

Compare PGIM India Healthcare Fund with Other Funds

Returns, risk, costs and the stocks they share, side by side

PGIM India Healthcare vs Nippon India Taiwan EquityThematic
PGIM India Healthcare vs HDFC DefenceThematic
PGIM India Healthcare vs HDFC Pharma and Healthcare52.5% overlap
PGIM India Healthcare vs SBI Healthcare OpportunitiesThematic
PGIM India Healthcare vs Aditya Birla Sun Life International EquityThematic
PGIM India Healthcare vs Mirae Asset Healthcare54.0% overlap
PGIM India Healthcare vs ITI Pharma and Healthcare53.2% overlap
PGIM India Healthcare vs Mirae Asset Nifty 500 Healthcare ETF53.0% overlap

Compare with any other fund

Frequently Asked Questions for PGIM India Healthcare Fund

What is the current NAV of PGIM India Healthcare Fund?

The Direct plan NAV is ₹12.10. The Regular plan NAV is ₹11.71, as on 30-10-2026.

What are the returns of PGIM India Healthcare Fund?

The Direct plan returned +18.05% in 1 year. The Regular plan returned +16.06% in 1 year. These figures are as on 30-10-2026.

What is the expense ratio of PGIM India Healthcare Fund?

The Direct plan charges 0.98% a year. The Regular plan charges 2.65% a year. This is the figure the fund house reported to AMFI, in force from 20-10-2026.

What is the AUM of PGIM India Healthcare Fund?

PGIM India Healthcare Fund managed ₹130.33 Cr on 30-09-2026, as its fund house reported in its monthly portfolio.

What are the top holdings of PGIM India Healthcare Fund?

At the end of September 2026 the largest holdings were DIVISLAB (10.36%), SUNPHARMA (10.25%), TORNTPHARM (8.49%), AJANTPHARM (4.96%), MAXHEALTH (4.71%). The fund held 31 securities in all.

What did PGIM India Healthcare Fund buy and sell in September 2026?

It bought 2 new stocks: Molbio Diagnostics Ltd, Symbiotec Pharmalab Ltd. It sold out of 2: Pfizer Ltd, Dr Agarwal's Health Care Ltd. It added shares in 16. It reduced 1.

How do I invest in PGIM India Healthcare Fund?

Through PGIM India Mutual Fund's website or app, a mutual fund distributor, or an investment platform. Choose the Direct plan to pay no distributor commission, or the Regular plan to invest through a distributor. The first investment is at least ₹5,000. You can invest once or through a monthly SIP.

Who is the fund manager of PGIM India Healthcare Fund?

Anandha Padmanabhan Anjeneyan (since 06-12-2024), Utsav Mehta (since 06-12-2024), Vivek Sharma (since 06-12-2024), and Mr. Puneet Pal (since 06-12-2024).

Sources: NAV and expense ratio from AMFI. Holdings from the fund house's monthly portfolio statement. Fund facts from its scheme summary document, as on 16-10-2026.

This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.